105 related articles for article (PubMed ID: 9585816)
21. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones.
Bonneau RH; Salvucci LA; Johnson DC; Tevethia SS
Virology; 1993 Jul; 195(1):62-70. PubMed ID: 7686314
[TBL] [Abstract][Full Text] [Related]
22. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
[TBL] [Abstract][Full Text] [Related]
23. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease.
Hendricks RL; Weber PC; Taylor JL; Koumbis A; Tumpey TM; Glorioso JC
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1601-10. PubMed ID: 1649898
[TBL] [Abstract][Full Text] [Related]
24. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms underlying chemical sympathectomy-induced suppression of herpes simplex virus-specific cytotoxic T lymphocyte activation and function.
Leo NA; Bonneau RH
J Neuroimmunol; 2000 Oct; 110(1-2):45-56. PubMed ID: 11024533
[TBL] [Abstract][Full Text] [Related]
26. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
Osorio Y; Ghiasi H
J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
[TBL] [Abstract][Full Text] [Related]
27. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
[TBL] [Abstract][Full Text] [Related]
28. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
[TBL] [Abstract][Full Text] [Related]
29. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
30. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
31. Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice.
Rouse BT; Wagner H
Immunology; 1984 Jan; 51(1):57-64. PubMed ID: 6317545
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
Vasilakos JP; Michael JG
J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
[TBL] [Abstract][Full Text] [Related]
33. Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.
Martin S; Zhu XX; Silverstein SJ; Courtney RJ; Yao F; Jenkins FJ; Rouse BT
J Gen Virol; 1990 Oct; 71 ( Pt 10)():2391-9. PubMed ID: 2172452
[TBL] [Abstract][Full Text] [Related]
34. The regulation of herpes simplex virus-specific CTL induction by suppressor cells.
Horohov DW; Moore RN; Rouse BT
Viral Immunol; 1987; 1(1):55-68. PubMed ID: 2855699
[TBL] [Abstract][Full Text] [Related]
35. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
[TBL] [Abstract][Full Text] [Related]
36. Decreased herpes simplex viral immunity and enhanced pathogenesis following stressor administration in mice.
Kusnecov AV; Grota LJ; Schmidt SG; Bonneau RH; Sheridan JF; Glaser R; Moynihan JA
J Neuroimmunol; 1992 May; 38(1-2):129-37. PubMed ID: 1315793
[TBL] [Abstract][Full Text] [Related]
37. Differential in vitro activation of CD4+CD8- and CD8+CD4- herpes simplex virus-specific human cytotoxic T cells.
Yasukawa M; Inatsuki A; Kobayashi Y
J Immunol; 1989 Sep; 143(6):2051-7. PubMed ID: 2476493
[TBL] [Abstract][Full Text] [Related]
38. Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo.
Fernandez MA; Evans IA; Hassan EH; Carbone FR; Jones CA
Eur J Immunol; 2008 Jan; 38(1):102-13. PubMed ID: 18081035
[TBL] [Abstract][Full Text] [Related]
39. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
40. HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.
Maccario R; Revello MG; Comoli P; Montagna D; Locatelli F; Gerna G
J Immunol; 1993 Feb; 150(4):1437-45. PubMed ID: 8381835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
